Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study.

J Clin Med · 2025 · PMC12470872 · PMID 41010578

Europe PMC DOI

hedged sentence

0.1560

closest p · 3.1× alpha

0.1560

boldest claim

The sentences

did not reach statistical significancep = 0.156not close (p > 0.1)

Lastly, although the presence of cardiometabolic comorbidities did not reach statistical significance, a trend was observed (61.2% vs. 66.7% in patients without cardiometabolic comorbidities, p = 0.156) ( Figure 1 d).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.